Predictors of Lymphedema Following Breast Cancer Surgery

This study has been completed.
Sponsor:
Collaborator:
U.S. Army Medical Research and Materiel Command
Information provided by:
Park Nicollet Institute
ClinicalTrials.gov Identifier:
NCT00202046
First received: September 13, 2005
Last updated: September 16, 2009
Last verified: April 2007
  Purpose

The purpose of this study evaluate which factors play a role in lymphedema development among women who have had axillary surgery for breast cancer. Potential risk factors for women who have developed lymphedema will be compared to risk factors among women who have not developed lymphedema after breast cancer surgery.


Condition
Breast Cancer
Lymphedema

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Predictors of Lymphedema Following Breast Cancer Surgery

Resource links provided by NLM:


Further study details as provided by Park Nicollet Institute:

Estimated Enrollment: 200
Study Start Date: January 2003
Study Completion Date: May 2008
Detailed Description:

Surgery for breast cancer includes removal of the breast tumor along with the axillary lymph nodes. The status of these nodes helps clinicians determine prognosis and guides treatment decisions. Unfortunately, a relatively common side effect following axillary lymph node dissection is upper-extremity lymphedema. The purpose of this study is to identify risk factors for lymphedema among women who have had axillary surgery for breast cancer. Specific aims include identifying risk factors for lymphedema and comparing quality of life (QOL) ratings for women who have and do not have lymphedema. A case-control study will be conducted with enrollment of 200 participants. Cases will be identified at their lymphedema consult in the physical therapy centers. Using the oncology registry, controls will include patients who have had breast cancer surgery and have not developed lymphedema. The severity of lymphedema and interference with daily life will be assessed with the Measure of Arm Symptom Survey (MASS), a patient-completed survey, and QOL will be collected with the SF-36. Treatment risk factors including previous surgery, radiotherapy and chemotherapy will be obtained from oncology registry data. This study will determine which factors play a role in lymphedema development.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Women with upper-extremety lymphedema(prevalent and incident cases) are identified at the time they presented to the physical therapy department or cancer center at 5 participating institutions (Park Nicollet health Services, fairview-University Medical Center, Fairview Southdale medical Center, North Memorial medical Center, and healthEast Care System). Controls were identified through the oncology Registry.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of lymphedema
  • Axillary node surgery by sentinel node or axillary node dissection
  • No known metastatic disease in the axilla
  • Able and willing to give informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00202046

Locations
United States, Minnesota
Fairview University
Minneapolis, Minnesota, United States, 55455
North Memorial Medical Center
Minneapolis, Minnesota, United States, 55422
Park Nicollet Institute
St. Louis Park, Minnesota, United States, 55416
Sponsors and Collaborators
Park Nicollet Institute
U.S. Army Medical Research and Materiel Command
Investigators
Principal Investigator: Karen K Swenson, RN, MS, PhDc Park Nicollet Institute
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00202046     History of Changes
Other Study ID Numbers: 1728-03-B, DAMD17-03-0738
Study First Received: September 13, 2005
Last Updated: September 16, 2009
Health Authority: United States: Federal Government

Keywords provided by Park Nicollet Institute:
Breast cancer
Lymphedema
Quality of life

Additional relevant MeSH terms:
Breast Neoplasms
Lymphedema
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases
Lymphatic Diseases

ClinicalTrials.gov processed this record on April 15, 2014